FI95203C - Analogiamenetelmä sytotoksisen koostumuksen valmistamiseksi - Google Patents
Analogiamenetelmä sytotoksisen koostumuksen valmistamiseksiInfo
- Publication number
- FI95203C FI95203C FI874852A FI874852A FI95203C FI 95203 C FI95203 C FI 95203C FI 874852 A FI874852 A FI 874852A FI 874852 A FI874852 A FI 874852A FI 95203 C FI95203 C FI 95203C
- Authority
- FI
- Finland
- Prior art keywords
- cytotoxic agent
- preparing
- analogous process
- cytotoxic composition
- instilled
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 231100000433 cytotoxic Toxicity 0.000 title 1
- 230000001472 cytotoxic effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 4
- 239000002254 cytotoxic agent Substances 0.000 abstract 4
- 231100000599 cytotoxic agent Toxicity 0.000 abstract 3
- 208000008516 Capsule Opacification Diseases 0.000 abstract 1
- 208000002177 Cataract Diseases 0.000 abstract 1
- 210000002159 anterior chamber Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 210000002919 epithelial cell Anatomy 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 231100000065 noncytotoxic Toxicity 0.000 abstract 1
- 230000002020 noncytotoxic effect Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
- A61K47/6827—Ricin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6845—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a cytokine, e.g. growth factors, VEGF, TNF, a lymphokine or an interferon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Lubricants (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Liquid Crystal Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92731886A | 1986-11-04 | 1986-11-04 | |
| US92731886 | 1986-11-04 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI874852A0 FI874852A0 (fi) | 1987-11-03 |
| FI874852L FI874852L (fi) | 1988-05-05 |
| FI95203B FI95203B (fi) | 1995-09-29 |
| FI95203C true FI95203C (fi) | 1996-01-10 |
Family
ID=25454561
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI874852A FI95203C (fi) | 1986-11-04 | 1987-11-03 | Analogiamenetelmä sytotoksisen koostumuksen valmistamiseksi |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0267005B1 (fi) |
| JP (1) | JPH07121878B2 (fi) |
| AT (1) | ATE83666T1 (fi) |
| AU (1) | AU608257B2 (fi) |
| CA (1) | CA1338777C (fi) |
| DE (1) | DE3783211T2 (fi) |
| DK (1) | DK575487A (fi) |
| ES (1) | ES2053561T3 (fi) |
| FI (1) | FI95203C (fi) |
| GR (1) | GR3007052T3 (fi) |
| IE (1) | IE60436B1 (fi) |
| NO (1) | NO173974C (fi) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE121299T1 (de) * | 1987-12-31 | 1995-05-15 | Tanox Biosystems Inc | Antigene epitope, die sich ausschliesslich auf ige-tragenden b-lymphocyten befinden. |
| WO1995003783A1 (en) * | 1990-03-06 | 1995-02-09 | Houston Biotechnology Incorporated | Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract |
| US5876438A (en) * | 1993-08-02 | 1999-03-02 | Houston Biotechnology Incorporated | Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract |
| US5620013A (en) * | 1994-10-21 | 1997-04-15 | American Cyanamid Company | Method for destroying residual lens epithelial cells |
| US6063116A (en) * | 1994-10-26 | 2000-05-16 | Medarex, Inc. | Modulation of cell proliferation and wound healing |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0044167A3 (en) * | 1980-07-14 | 1982-04-21 | The Regents Of The University Of California | Antibody targeted cytotoxic agent |
| US4432751A (en) * | 1982-03-05 | 1984-02-21 | Baylor College Of Medicine | Monoclonal antibodies against lens epithelial cells and preventing proliferation of remnant lens epithelial cells after extracapsular extraction |
| DE3483996D1 (de) * | 1983-09-15 | 1991-02-28 | Univ Leland Stanford Junior | Allotransplantat mit verminderter immunogenitaet und verfahren und reagenz fuer seine herstellung. |
| EP0173648A3 (en) * | 1984-08-30 | 1988-04-27 | Ciba-Geigy Ag | New monoclonal antibodies to glycoconjugates, processes for their production, and applications |
| US4590071A (en) * | 1984-09-25 | 1986-05-20 | Xoma Corporation | Human melanoma specific immunotoxins |
-
1987
- 1987-11-03 DK DK575487A patent/DK575487A/da not_active Application Discontinuation
- 1987-11-03 CA CA000550962A patent/CA1338777C/en not_active Expired - Fee Related
- 1987-11-03 NO NO874569A patent/NO173974C/no not_active IP Right Cessation
- 1987-11-03 ES ES87309722T patent/ES2053561T3/es not_active Expired - Lifetime
- 1987-11-03 EP EP87309722A patent/EP0267005B1/en not_active Expired - Lifetime
- 1987-11-03 AT AT87309722T patent/ATE83666T1/de not_active IP Right Cessation
- 1987-11-03 DE DE8787309722T patent/DE3783211T2/de not_active Expired - Fee Related
- 1987-11-03 FI FI874852A patent/FI95203C/fi not_active IP Right Cessation
- 1987-11-04 AU AU80666/87A patent/AU608257B2/en not_active Ceased
- 1987-11-04 IE IE297787A patent/IE60436B1/en not_active IP Right Cessation
- 1987-11-04 JP JP62279011A patent/JPH07121878B2/ja not_active Expired - Fee Related
-
1993
- 1993-02-11 GR GR930400284T patent/GR3007052T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE60436B1 (en) | 1994-07-13 |
| NO173974B (no) | 1993-11-22 |
| GR3007052T3 (fi) | 1993-07-30 |
| NO173974C (no) | 1994-03-02 |
| CA1338777C (en) | 1996-12-10 |
| EP0267005A2 (en) | 1988-05-11 |
| AU608257B2 (en) | 1991-03-28 |
| NO874569D0 (no) | 1987-11-03 |
| JPH07121878B2 (ja) | 1995-12-25 |
| FI874852L (fi) | 1988-05-05 |
| EP0267005B1 (en) | 1992-12-23 |
| DK575487D0 (da) | 1987-11-03 |
| DK575487A (da) | 1988-05-05 |
| EP0267005A3 (en) | 1989-11-08 |
| JPS63211239A (ja) | 1988-09-02 |
| DE3783211T2 (de) | 1993-04-29 |
| NO874569L (no) | 1988-05-05 |
| FI95203B (fi) | 1995-09-29 |
| ATE83666T1 (de) | 1993-01-15 |
| FI874852A0 (fi) | 1987-11-03 |
| IE872977L (en) | 1988-05-04 |
| DE3783211D1 (de) | 1993-02-04 |
| ES2053561T3 (es) | 1994-08-01 |
| AU8066687A (en) | 1988-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE133667T1 (de) | Thiazolderivate, verfahren zur ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten | |
| IE35642B1 (en) | A process for the preparation of new alpha-aminopenicillins and such penicillins and intermediates and pharmaceutical preparations | |
| IE830467L (en) | Monoclonal antibodies against lens epithelial cells | |
| JPS55136266A (en) | Derivatives of 2-imidazoline | |
| FI95203C (fi) | Analogiamenetelmä sytotoksisen koostumuksen valmistamiseksi | |
| ES8600272A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-sulfamoilbenzo (b) tiofeno. | |
| BG30324A3 (bg) | Метод за получаване на 4-субституирани тиазолоксамови киселини, техни соли и естери | |
| ES8104202A1 (es) | Procedimiento para la preparacion de un derivado insulinico | |
| NL7415883A (nl) | Werkwijze voor het bereiden van oogheelkundige preparaten. | |
| IE38096L (en) | Pharmaceutically active phenylpropionic acid preparations | |
| GB810232A (en) | Improvements in artificial intraocular lenses | |
| GB1188846A (en) | Thiazole Derivatives | |
| ES450799A1 (es) | Un procedimiento para la preparacion de nuevas 3-fenilespino(esobenzofuran-1,4'-piperidemo) sulfenamidas y derivados. | |
| JPS52282A (en) | Process for preparation of carbostyril derivatives | |
| EP0372071A4 (en) | MONOCLONAL ANTIBODIES AGAINST LENTIL EPITHELIC CELLS AND METHODS FOR PREVENTING THE PROPAGATION OF REMAINING LENS LENSING EPITHELIAL CELLS AFTER EXTRACAPSULAR EXTRACTION. | |
| ES2085323T3 (es) | Compuestos de espiro-indolin-oxazina con caracteristicas fotocromaticas y fotosensibilizantes y el procedimiento para su preparacion. | |
| ES483532A1 (es) | Procedimiento para la obtencion de derivados de acido a-ami-nofenilacetico. | |
| JPS52263A (en) | Process for preparation of 1-alkanesulfonyloxy alkyl-2-alkyl-3-dipheny lmethylenepyrrolidine and its salts | |
| SE424990B (sv) | Analogiforfarande for framstellning av 10,11-dihydro-3-karboxi-cyproheptadin och dess n-oxid | |
| SU670543A1 (ru) | Стекло дл спаивани с металлом | |
| ES8102126A1 (es) | Procedimiento para la produccion e una composicion sinergis-tica a base de derivados de naftiridina | |
| KR790000048B1 (en) | Process for preparation of 6,7- benzomorphan derivatives | |
| 陳德照 et al. | Results in 100 Intraocular Lens Implantations-Preliminary Reports | |
| ES349266A1 (es) | Procedimiento para la preparacion de esteroido-oxazolinas. | |
| JPS5418832A (en) | Preparation of hetericyclic dyes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed |
Owner name: BAYLOR COLLEGE OF MEDICINE |